Drug intelligence / Profile preview

Sublivac Grasses

Development stage
Phase 3
Lead developer
HAL Allergy
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Sublivac Grasses is a sublingual allergen extract immunotherapy indicated for the treatment of IgE-mediated allergic rhinitis, allergic conjunctivitis, and mild allergic asthma triggered by grass pollen. It is designed to induce immune tolerance to specific grass pollens through repeated sublingual administration. The formulation contains allergen extracts from Lolium perenne (perennial ryegrass), Phleum pratense (timothy grass), and Poa pratensis (Kentucky bluegrass). The mechanism of action involves immunomodulation—specifically, the induction of immune tolerance by shifting the immune response away from an IgE-mediated pathway. This therapy is suitable for both adults and children aged five years and older with confirmed diagnosis via skin prick test or serum-specific IgE testing[1][6]. Clinical studies have demonstrated that sublingual immunotherapy with grass pollen extracts can reduce symptoms and medication use in patients with seasonal allergies[1][6][10].

Brand names
Sublivac Grasses
Other names
SUBLIVAC GrassesSUBLIVAC® GrassesSublivac grassen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Sublivac Grasses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sublivac Grasses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call